Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge
Priya Nori, Kelsie Cowman, Victor Chen, Rachel Bartash, Wendy Szymczak, Theresa Madaline, Chitra Punjabi Katiyar, Ruchika Jain, Margaret Aldrich, Gregory Weston, Philip Gialanella, Marilou Corpuz, Inessa Gendlina, Yi Guo
Abstract
We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6-7 days, and 79% had received prior antibiotics. Metallo-β-lactamase-producing E. cloacae coinfections occurred in 5 patients.
Topics & Concepts
MedicinePandemicBacteremiaCoronavirus disease 2019 (COVID-19)Internal medicineAntibioticsMicrobiologyBiologyDiseaseInfectious disease (medical specialty)Antibiotic Use and ResistanceCOVID-19 Clinical Research StudiesAntibiotic Resistance in Bacteria